Shu Du

456 total citations
13 papers, 355 citations indexed

About

Shu Du is a scholar working on Molecular Biology, Ophthalmology and Neurology. According to data from OpenAlex, Shu Du has authored 13 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Ophthalmology and 5 papers in Neurology. Recurrent topics in Shu Du's work include Retinal Diseases and Treatments (7 papers), RNA regulation and disease (3 papers) and Neuroinflammation and Neurodegeneration Mechanisms (3 papers). Shu Du is often cited by papers focused on Retinal Diseases and Treatments (7 papers), RNA regulation and disease (3 papers) and Neuroinflammation and Neurodegeneration Mechanisms (3 papers). Shu Du collaborates with scholars based in China. Shu Du's co-authors include Guangping Zhang, Yuanyuan Tu, Manhui Zhu, Yan Jiang, Linling Zhu, Yang Guo, Jing Liu, Yan Jin, Yinhui Qin and Yuting Zhang and has published in prestigious journals such as Brain Research, Investigative Ophthalmology & Visual Science and Oxidative Medicine and Cellular Longevity.

In The Last Decade

Shu Du

13 papers receiving 354 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shu Du China 10 197 90 82 57 38 13 355
Caibin Deng China 9 264 1.3× 133 1.5× 122 1.5× 75 1.3× 62 1.6× 14 438
Xiuju Chen China 12 158 0.8× 57 0.6× 68 0.8× 21 0.4× 43 1.1× 35 423
Anna Walczak Poland 12 265 1.3× 100 1.1× 32 0.4× 28 0.5× 48 1.3× 24 491
Fang Lu China 14 198 1.0× 38 0.4× 43 0.5× 26 0.5× 83 2.2× 33 468
Veronica Sfredel Romania 10 101 0.5× 49 0.5× 26 0.3× 42 0.7× 21 0.6× 25 318
Xiaopeng Yang China 11 125 0.6× 64 0.7× 60 0.7× 23 0.4× 26 0.7× 26 391
Shuo Huang United States 14 305 1.5× 74 0.8× 152 1.9× 61 1.1× 35 0.9× 20 530
Lei Xia China 9 176 0.9× 34 0.4× 37 0.5× 86 1.5× 68 1.8× 15 386
Hyoung Oh Jun South Korea 14 302 1.5× 80 0.9× 171 2.1× 36 0.6× 46 1.2× 19 503
Jianyan Hu China 14 265 1.3× 70 0.8× 190 2.3× 35 0.6× 46 1.2× 24 469

Countries citing papers authored by Shu Du

Since Specialization
Citations

This map shows the geographic impact of Shu Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu Du more than expected).

Fields of papers citing papers by Shu Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shu Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu Du. The network helps show where Shu Du may publish in the future.

Co-authorship network of co-authors of Shu Du

This figure shows the co-authorship network connecting the top 25 collaborators of Shu Du. A scholar is included among the top collaborators of Shu Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shu Du. Shu Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
2.
Zhang, Xiaoli, Shu Du, Xuemei Jin, et al.. (2023). LncRNA MALAT1 knockdown inhibits the development of choroidal neovascularization. Heliyon. 9(9). e19503–e19503. 3 indexed citations
3.
4.
Wang, Ying, Manhui Zhu, Yang Guo, et al.. (2021). Shikonin alleviates choroidal neovascularization by inhibiting proangiogenic factor production from infiltrating macrophages. Experimental Eye Research. 213. 108823–108823. 10 indexed citations
5.
Zhu, Manhui, Ying Wang, Linling Zhu, et al.. (2021). Crosstalk Between RPE Cells and Choroidal Endothelial Cells via the ANXA1/FPR2/SHP2/NLRP3 Inflammasome/Pyroptosis Axis Promotes Choroidal Neovascularization. Inflammation. 45(1). 414–427. 14 indexed citations
6.
Tu, Yuanyuan, Lele Li, Linling Zhu, et al.. (2021). Geniposide Attenuates Hyperglycemia‐Induced Oxidative Stress and Inflammation by Activating the Nrf2 Signaling Pathway in Experimental Diabetic Retinopathy. Oxidative Medicine and Cellular Longevity. 2021(1). 9247947–9247947. 46 indexed citations
7.
Wang, Ying, Quan Li, Xiaoyan Ji, et al.. (2021). The HIF‐1α/p53/miRNA‐34a/Klotho axis in retinal pigment epithelial cells promotes subretinal fibrosis and exacerbates choroidal neovascularization. Journal of Cellular and Molecular Medicine. 25(3). 1700–1711. 24 indexed citations
8.
Wang, Ying, et al.. (2021). The P300/XBP1s/Herpud1 axis promotes macrophage M2 polarization and the development of choroidal neovascularization. Journal of Cellular and Molecular Medicine. 25(14). 6709–6720. 24 indexed citations
9.
Zhou, Yamei, Jia Zeng, Yuanyuan Tu, et al.. (2021). CSF1/CSF1R-mediated Crosstalk Between Choroidal Vascular Endothelial Cells and Macrophages Promotes Choroidal Neovascularization. Investigative Ophthalmology & Visual Science. 62(3). 37–37. 20 indexed citations
10.
11.
Tu, Yuanyuan, Ying Wang, Xun Xu, et al.. (2019). Prodrug of epigallocatechin-3-gallate alleviates choroidal neovascularization via down-regulating HIF-1α/VEGF/VEGFR2 pathway and M1 type macrophage/microglia polarization. Biomedicine & Pharmacotherapy. 121. 109606–109606. 51 indexed citations
12.
Jiang, Yan, Jing Liu, Yan Jin, et al.. (2019). Serum secreted miR-137-containing exosomes affects oxidative stress of neurons by regulating OXR1 in Parkinson’s disease. Brain Research. 1722. 146331–146331. 94 indexed citations
13.
Liu, Jing, et al.. (2019). Protective effect of edaravone on blood-brain barrier by affecting NRF-2/HO-1 signaling pathway. Experimental and Therapeutic Medicine. 18(4). 2437–2442. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Caibin Deng Breakdown of academic impact, for papers by Xiuju Chen Breakdown of academic impact, for papers by Anna Walczak Breakdown of academic impact, for papers by Fang Lu Breakdown of academic impact, for papers by Veronica Sfredel Breakdown of academic impact, for papers by Xiaopeng Yang Breakdown of academic impact, for papers by Shuo Huang Breakdown of academic impact, for papers by Lei Xia Breakdown of academic impact, for papers by Hyoung Oh Jun Breakdown of academic impact, for papers by Jianyan Hu
Rankless by CCL
2026